Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
J Dermatol. 2021 Apr;48(4):519-528. doi: 10.1111/1346-8138.15706. Epub 2021 Jan 17.
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome has been described as a rare and distinct clinical phenotype of PSTPIP1-associated inflammatory diseases. We report PSTPIP1 mutation in both father and son who have leukopenia and acne-like lesions. Through whole-exome sequencing on blood DNA, it is found a heterozygous mutation of PSTPIP1 gene c.748G>A on the father and son. The diagnosis of PAMI is made based on DNA sequencing results and clinical characteristics of typical lesions, leukopenia, and the markedly increased serum S100A8/A9 (calprotectin).
PSTPIP1 相关髓系相关蛋白血症炎症(PAMI)综合征已被描述为 PSTPIP1 相关炎症性疾病的一种罕见且独特的临床表型。我们报告了一对父子的 PSTPIP1 突变病例,他们都有白细胞减少和痤疮样病变。通过对血液 DNA 进行全外显子测序,发现父亲和儿子的 PSTPIP1 基因 c.748G>A 存在杂合突变。根据 DNA 测序结果和典型病变、白细胞减少和显著升高的血清 S100A8/A9(钙卫蛋白)的临床特征,诊断为 PAMI。